Borylated reagents for multicomponent reactions.

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Chemical Biology

Background:

• The discovery of bortezomib (Velcade) has spurred significant interest in organoboron reagents for therapeutic applications.
• Synthetic chemists are actively developing new strategies for synthesizing heteroatom-rich boron-containing molecules (BCMs).
• Borylated building blocks offer efficient pathways to complex, previously inaccessible BCMs.

Purpose of the Study:

• To review synthetic methodologies for preparing biologically relevant boron-containing molecules.
• To highlight the utility of borylated building blocks in multicomponent reactions.
• To provide insights into the expanding field of organoboron chemistry for drug discovery.

Main Methods:

• Utilizing multicomponent reactions (MCRs) for streamlined synthesis.
• Employing pre-functionalized borylated building blocks.
• Exploring diverse reaction conditions for efficient BCM formation.

Main Results:

• Demonstrated facile access to a range of heteroatom-rich BCMs.
• Showcased the versatility of borylated building blocks in MCRs.
• Highlighted the potential of these methods for generating drug-like molecules.

Conclusions:

• Multicomponent reactions with borylated building blocks are powerful tools for synthesizing biologically relevant boron-containing molecules.
• This approach accelerates the discovery and development of novel therapeutic agents.
• The field of organoboron chemistry continues to offer exciting opportunities in medicinal chemistry.